anbenitamab
alphamab
['kn026']
poster highlighting phase ii clinical study of kn026 for her2-expressing advanced gc/gej presented at 2022 asco 
The Headlines of Today is a World News Website, Provide World News, International Breaking News, Tech , spots and entertainment News